Race Oncology (ASX:RAC) has completed its Phase 1b/2 trial of bisantrene in combination with clofarabine and fludarabine for the treatment of relapsed or refractory acute myeloid leukaemia.
Oct 2024 - Nick Scali Limited (ASX:NCK) has reported strong financial performance for FY24, driven by a gross margin increase to 66% across its Australian and New Zealand operations.
Oct 2024 - Hazer Group Limited (ASX:HZR) continues to make significant progress with its clean hydrogen production technology, as highlighted in its latest quarterly report for the period ending 30 ...
Oct 2024 - Mineral Resources Limited (ASX:MIN) is addressing governance issues following recent media reports concerning Managing Director Chris Ellison.
Oct 2024 - Strike Energy (ASX:STX) has announced remarkable production testing results from its Erregulla Deep-1 (ED-1) gas well, solidifying its potential impact on the West Erregulla gas field ...
Oct 2024 - PYC Therapeutics (ASX:PYC) has received Orphan Drug Designation from the US Food and Drug Administration for its drug candidate VP-001, aimed at treating Retinitis Pigmentosa type 11.